OMedLive, an online oncology learning channel of PlatformQ Health Education, will be in Chicago for the 2017 ASCO Annual Meeting next week. Our commitment to oncology practice and cancer care makes this one of the most exciting events for our team, as four of our fifteen therapeutically-aligned learning channels are closely tied to the core stakeholders that ASCO draws each year.

Stop by our booth in the exhibit hall, BOOTH NUMBER 2075 (near the patient advocacy pavilion), to learn more about how we’re delivering trustworthy educational programming to change how clinicians and patients learn about – and act on – the most timely, relevant, reliable disease and therapeutic information available.

We’ll discuss our recognized leadership in outcomes-centric education across our dedicated learning channels for clinicians and patients, OMedLive and CancerCoachLive, as well as our more specialized channels, RareUniversity and VirtualProstateSummit. Each learning channel mirrors what would be found at a live medical conference, including live-streaming video lectures, panel discussions and case presentations, as well as interactive activities like real-time question and answer sessions with top faculty and other participants.


Our oncology channel for clinicians featuring free CME and non-accredited education.
A patient-focused learning channel aimed at empowering those touched by cancer through education.
Our prostate health channel for clinicians specializing in men’s health.
A rare disease education platform dedicated to aligning and increasing the availability resources for patients, caregivers, advocates and clinicians.


We’re proud to announce PlatformQ Health has 4 abstracts accepted for publication for the 2017 ASCO Annual Meeting. Read more about these abstracts, our approach to measuring outcomes here.

Please keep an eye out for our team and make sure you stop by booth 2075 to hear more about how we’re innovating medical education for clinicians and patients.

Not attending the ASCO Annual Meeting this year? Email us at for more information.